Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Improved Brain Implants Could Help Control Neuronal Networks

By HospiMedica International staff writers
Posted on 21 Oct 2015
A new type of nanowire material might improve the longevity of neuroprosthetic brain implants used to treat Parkinson’s disease (PD) and other neurological diseases.

The new nanowires, developed by researchers at Lund University (Sweden), are made from gallium phosphide, where each outgrowing nanowire has a diameter of only 80 nanometers. More...
The dense array of vertical nanowires is intercalated with flat surface regions to separate retinal neurons and glial cells into distinct, but neighboring, compartments. Thus, while neurons grow and extend processes on the nanowires, the glial cells primarily occupy the flat regions in between.

According to the researchers, the need for the new nanowires results from several severe drawbacks associated with current implants. One problem is that the body interprets the implants as foreign objects, resulting in an encapsulation of the electrode, which in turn leads to loss of signal. Another problem is that in neural cultures, glial cells tend to overgrow neurons, limiting access to neuronal interrogation. There is therefore a pressing need for improved systems that enable a good separation when co-culturing neurons and glial cells simultaneously.

Besides use as brain implants for PD and other neurological deficits, the researchers have also developed a nanowire patterning capable of guiding optic nerve axons, which could be used as retinal implants able to replace light-sensitive cells that die in cases of Retinitis Pigmentosa and other eye diseases. The neural implants can be used in many other areas as well, such as in treating depression, severe cases of autism, obsessive-compulsive disorders, and paralysis. The study describing the new nanowires was published on August 11, 2015, in ACS Applied Materials and Interfaces.

“I was very pleasantly surprised by these results; in previous in vitro experiments, the glial cells usually attach strongly to the electrodes”, said senior author Christelle Prinz, PhD, a researcher in Nanophysics at Lund University. “Our nanowire structure prevents the cells that usually encapsulate the electrodes from doing so. The different types of cells continue to interact; this is necessary for the neurons to survive because the glial cells provide them with important molecules.”

Neuronal survival and function are greatly dependent on glial cell support, and even in vitro glial cells control the number of synapses and increase the synaptic efficacy in neuronal cultures. Direct proximity of neurons to glial cells has also been shown to be necessary to support long-term potentiation, a mechanism that underlies learning and memory. Thus, to ensure that cultured neurons behave as closely as possible to neurons in the in vivo situation, it is important that they are cultured together with glial cells.

Related Links:

Lund University



Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Ultrasound Needle Guidance System
SonoSite L25
Endoscopy Display
E190
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.